JCS-Logo-AI.png
JCS Solutions Engages Federal Digital Transformation Executive Carter Raines as First Chief Growth Officer
September 03, 2024 07:15 ET | JCS Solutions
Carter Raines, a federal digital transformation executive, has joined JCS Solutions as its first Chief Growth Officer.
topbuild_logo.png
TopBuild to Participate in Fireside Chat at Jefferies Industrials Conference
September 03, 2024 07:15 ET | TopBuild Corp.
DAYTONA BEACH, Fla., Sept. 03, 2024 (GLOBE NEWSWIRE) -- TopBuild Corp. (NYSE:BLD), a leading installer and specialty distributor of insulation and related building material products to the...
ADCT_4C_TM-R .png
ADC Therapeutics to Present at Upcoming Investor Conferences
September 03, 2024 07:15 ET | ADC Therapeutics SA
LAUSANNE, Switzerland, Sept. 03, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today...
emerge.png
Emergent BioSolutions Successfully Refinances Debt & Further Strengthens Financial Profile
September 03, 2024 07:08 ET | Emergent BioSolutions
GAITHERSBURG, Md., Sept. 03, 2024 (GLOBE NEWSWIRE) --  Emergent BioSolutions Inc. (NYSE: EBS) today announced the closing of a new credit facility agreement with Oak Hill Advisors for a term loan of...
Goliath BC - logo with gradient gold-justified.png
Goliath Intercepts The Highest Concentration Of Visible Gold To Date At Surebet Where 66% Of 2024 Drill Holes Contain Visible Gold, Discovers New Deep Mineralized Zone 1.2 Km Below Surface, Remains Open, And Significantly Expands Drilling To 36,000 Meters With 8 Rigs Turning
September 03, 2024 07:08 ET | Goliath Resources Limited
Surebet Drill Highlights: Drill hole GD-24-260 has the highest concentration of Visible Gold drilled to date at the Surebet Discovery. This intercept suggests this structure is a principal conduit...
New logo with tagline.jpg
Vaxcyte Reports Positive Topline Data from Phase 1/2 Study of VAX-31, its 31-Valent Pneumococcal Conjugate Vaccine Candidate, in Adults Aged 50 and Older
September 03, 2024 07:07 ET | Vaxcyte, Inc.
-- At All Doses Studied, VAX-31 Demonstrated Robust Opsonophagocytic Activity Immune Responses for All 31 Serotypes -- -- At Middle and High Doses, VAX-31 Met or Exceeded Regulatory Immunogenicity...
AMR Logo.png
Video Conferencing Solutions Market to Reach $49.7 Billion, Globally, by 2032 at 13.7% CAGR: Allied Market Research
September 03, 2024 07:07 ET | Allied Analytics LLP
NEW CASTLE, Delaware, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Video Conferencing Solutions Market by Deployment Mode (On-premise and Cloud), by...
RGRD Logo BusinessWire.jpg
DXCM INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead Case
September 03, 2024 07:05 ET | Robbins Geller Rudman & Dowd LLP
SAN DIEGO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces purchasers or acquirers of DexCom, Inc. (NASDAQ: DXCM) securities between January 8, 2024...
AMR Logo.png
Next-Gen Communication Protocols Market to Reach $259.3 Billion, Globally, by 2032 at 20.9% CAGR: Allied Market Research
September 03, 2024 07:05 ET | Allied Analytics LLP
NEW CASTLE, Delaware, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Next-Gen Communication Protocols Market by Technology (Wireless Communication...
full_colour.png
GH Research Reports Second Quarter 2024 Financial Results and Provides Business Updates
September 03, 2024 07:05 ET | GH Research PLC
Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024 and expected completion of 6-month open-label...